Your browser doesn't support javascript.
loading
To what extent should we lower HbA1c in diabetic subjects?
Hadjadj, S; Saulnier, P-J; Torremocha, F; Labbé, L; Maréchaud, R.
Affiliation
  • Hadjadj S; CHU de Poitiers, Department of Endocrinology Diabetology, 2, rue de la Milètrie, BP 577, 86021 Poitiers cedex, France. s.hadjadj@chu-poitiers.fr
Diabetes Metab ; 34 Suppl 1: S37-40, 2008 Feb.
Article in En | MEDLINE | ID: mdl-18358426
Current recommendations regarding glycemic control suggest that HbA(1c) should be lower than 6.5%. This is supported by data regarding microvascular disease, namely retinopathy rather than nephropathy. The question is not completely solved regarding cardiovascular diseases, where a strategy of very low HbA(1c) ("the lower the better") is expected to be effective. Some ongoing studies will help to answer these unsolved questions.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycated Hemoglobin / Diabetes Mellitus / Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Diabetes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2008 Document type: Article Affiliation country: France Country of publication: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycated Hemoglobin / Diabetes Mellitus / Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Diabetes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2008 Document type: Article Affiliation country: France Country of publication: France